Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
A nurse failed to properly fit the feeding tube of a four-week-old baby who died in the neonatal intensive care unit at Wales ...
Arvinas shows strong ESR1-mutant data with limited scope, niche SERD competition, Pfizer uncertainty, and a high-risk pipeline. See why ARVN stock is a hold.
Introduction Post-induction hypotension (PIH) is a critical concern in elderly surgical patients and is associated with adverse postoperative outcomes. This trial aims to compare the effects of ...
The placement of a permanent pacemaker is the definitive treatment for sinus node dysfunction, but not everyone needs this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results